Johnson & Johnson stopped short of implementing its proposal to alter the way two drugs are paid for under the 340B drug discount program, but the drugmaker made it clear it still wants changes. In ...

Maven Clinic, a virtual clinic for women’s and family health, has secured $125 million in Series F funding, the company announced Tuesday. New York City-based Maven Clinic offers support for ...

HLTH, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, spotlights individuals across the healthcare ecosystem from high-powered executives such as Fred Abnousi, the head of ...

Bipartisan Congressional scrutiny has shone a harsh spotlight on the many tactics used by pharmacy benefit managers (PBMs) and Big Pharma that contribute to the sky high costs of prescription ...

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Bayo Curry ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a ...

The 2024 election is nearing the corner and has major implications for the healthcare industry, from abortion to drug pricing. During the Reuters Total Health Conference held in Chicago on Tuesday ...

The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in "anticompetitive and unfair rebating practices” as it relates to insulin. One legal ...

There has been a huge demand for healthcare AI this year — with three-quarters of the country’s providers and payers having increased their IT spending over the past year. This enthusiasm for ...

The litigation tying up the Federal Trade Commission’s new rule prohibiting for-profit companies from requiring noncompete clauses gives everyone in healthcare time to consider the unique needs ...